Report Detail
Global Pharmacogenomics (PGx) Market Growth (Status and Outlook) 2019-2024
- RnM3145430 |
- 19 March, 2019 |
- Global |
- 130 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of an individual affects his/her response to drugs.
According to this study, over the next five years the Pharmacogenomics (PGx) market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmacogenomics (PGx) business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Pharmacogenomics (PGx) market by product type, application, key companies and key regions.
This study considers the Pharmacogenomics (PGx) value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Polymerase Chain Reaction (PCR)
Microarray
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Affymetrix, Inc.
Assurex Health, Inc
Astrazeneca
GeneDX
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
Pathway Genomics
Pfizer, Inc
Qiagen, Inc.
Rocheg
Teva Pharmaceutical Industries Ltd.
Thermo Fisher Scientific
Transgenomic, Inc.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pharmacogenomics (PGx) market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pharmacogenomics (PGx) market by identifying its various subsegments.
Focuses on the key global Pharmacogenomics (PGx) players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmacogenomics (PGx) with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pharmacogenomics (PGx) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Pharmacogenomics (PGx) Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmacogenomics (PGx) Market Size 2014-2024
- 2.1.2 Pharmacogenomics (PGx) Market Size CAGR by Region
- 2.2 Pharmacogenomics (PGx) Segment by Type
- 2.2.1 Polymerase Chain Reaction (PCR)
- 2.2.2 Microarray
- 2.2.3 Sequencing
- 2.2.4 Other
- 2.3 Pharmacogenomics (PGx) Market Size by Type
- 2.3.1 Global Pharmacogenomics (PGx) Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Pharmacogenomics (PGx) Market Size Growth Rate by Type (2014-2019)
- 2.4 Pharmacogenomics (PGx) Segment by Application
- 2.4.1 Cardiovascular Diseases (CVD)
- 2.4.2 Central Nervous System (CNS)
- 2.4.3 Cancer/Oncology
- 2.4.4 Infectious Diseases
- 2.4.5 Other
- 2.5 Pharmacogenomics (PGx) Market Size by Application
- 2.5.1 Global Pharmacogenomics (PGx) Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Pharmacogenomics (PGx) Market Size Growth Rate by Application (2014-2019)
3 Global Pharmacogenomics (PGx) by Players
- 3.1 Global Pharmacogenomics (PGx) Market Size Market Share by Players
- 3.1.1 Global Pharmacogenomics (PGx) Market Size by Players (2017-2019)
- 3.1.2 Global Pharmacogenomics (PGx) Market Size Market Share by Players (2017-2019)
- 3.2 Global Pharmacogenomics (PGx) Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenomics (PGx) by Regions
- 4.1 Pharmacogenomics (PGx) Market Size by Regions
- 4.2 Americas Pharmacogenomics (PGx) Market Size Growth
- 4.3 APAC Pharmacogenomics (PGx) Market Size Growth
- 4.4 Europe Pharmacogenomics (PGx) Market Size Growth
- 4.5 Middle East & Africa Pharmacogenomics (PGx) Market Size Growth
5 Americas
- 5.1 Americas Pharmacogenomics (PGx) Market Size by Countries
- 5.2 Americas Pharmacogenomics (PGx) Market Size by Type
- 5.3 Americas Pharmacogenomics (PGx) Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Pharmacogenomics (PGx) Market Size by Countries
- 6.2 APAC Pharmacogenomics (PGx) Market Size by Type
- 6.3 APAC Pharmacogenomics (PGx) Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Pharmacogenomics (PGx) by Countries
- 7.2 Europe Pharmacogenomics (PGx) Market Size by Type
- 7.3 Europe Pharmacogenomics (PGx) Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Pharmacogenomics (PGx) by Countries
- 8.2 Middle East & Africa Pharmacogenomics (PGx) Market Size by Type
- 8.3 Middle East & Africa Pharmacogenomics (PGx) Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Pharmacogenomics (PGx) Market Forecast
- 10.1 Global Pharmacogenomics (PGx) Market Size Forecast (2019-2024)
- 10.2 Global Pharmacogenomics (PGx) Forecast by Regions
- 10.2.1 Global Pharmacogenomics (PGx) Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Pharmacogenomics (PGx) Forecast by Type
- 10.8 Global Pharmacogenomics (PGx) Forecast by Application
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Company Details
- 11.1.2 Pharmacogenomics (PGx) Product Offered
- 11.1.3 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Abbott Laboratories News
- 11.2 Affymetrix, Inc.
- 11.2.1 Company Details
- 11.2.2 Pharmacogenomics (PGx) Product Offered
- 11.2.3 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Affymetrix, Inc. News
- 11.3 Assurex Health, Inc
- 11.3.1 Company Details
- 11.3.2 Pharmacogenomics (PGx) Product Offered
- 11.3.3 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Assurex Health, Inc News
- 11.4 Astrazeneca
- 11.4.1 Company Details
- 11.4.2 Pharmacogenomics (PGx) Product Offered
- 11.4.3 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Astrazeneca News
- 11.5 GeneDX
- 11.5.1 Company Details
- 11.5.2 Pharmacogenomics (PGx) Product Offered
- 11.5.3 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 GeneDX News
- 11.6 Illumina, Inc.
- 11.6.1 Company Details
- 11.6.2 Pharmacogenomics (PGx) Product Offered
- 11.6.3 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Illumina, Inc. News
- 11.7 Laboratory Corporation of America Holdings
- 11.7.1 Company Details
- 11.7.2 Pharmacogenomics (PGx) Product Offered
- 11.7.3 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Laboratory Corporation of America Holdings News
- 11.8 Myriad Genetics, Inc.
- 11.8.1 Company Details
- 11.8.2 Pharmacogenomics (PGx) Product Offered
- 11.8.3 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Myriad Genetics, Inc. News
- 11.9 Pathway Genomics
- 11.9.1 Company Details
- 11.9.2 Pharmacogenomics (PGx) Product Offered
- 11.9.3 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 Pathway Genomics News
- 11.10 Pfizer, Inc
- 11.10.1 Company Details
- 11.10.2 Pharmacogenomics (PGx) Product Offered
- 11.10.3 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Pfizer, Inc News
- 11.11 Qiagen, Inc.
- 11.12 Rocheg
- 11.13 Teva Pharmaceutical Industries Ltd.
- 11.14 Thermo Fisher Scientific
- 11.15 Transgenomic, Inc.
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Pharmacogenomics (PGx) . Industry analysis & Market Report on Pharmacogenomics (PGx) is a syndicated market report, published as Global Pharmacogenomics (PGx) Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Pharmacogenomics (PGx) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
